group pretreated with intravenous magnesium sulfate (0.27 mmol/kg)
(magnesium group, n = 19), and nonpretreated controls (placebo group).
靜脈注射硫酸鎂(0.27 mmol / kg)(鎂組,n = 19)和未預處理對照組(安慰劑組)。
The peak serum levels of interleukin-6 (IL-6) were significantly lower
in the magnesium group than those in the placebo group
(38.9 +/- 25.0 vs 92.3 +/- 76.5 pg/mL, p = 0.016).
鎂組的白細胞介素-6(IL-6)峰值血清水平顯著低於安慰劑組
The peak serum levels of matrix metalloproteinase-1 (MMP-1) were lower than
those in the placebo group (16.2 +/- 4.8 vs 19.7 +/- 9.0 ng/mL, p = 0.09),
but the difference was not significant.
基質金屬蛋白酶-1(MMP-1)峰值血清水平低於安慰劑組,但差異不顯著。
A positive correlation was observed between the peak MMP-1 values and
the peak IL-6 values (r = 0.57, p = 0.001) in all patients.
在所有患者中觀察到峰值MMP-1值與峰值IL-6值之間呈正相關。
能降低IL-6:鎂、鋅
The Avidity of Cell Surface αEβ7 Is Regulated
by removing calcium and elevating magnesium,
leads to increased adhesion to E-cadherin–Fc.
通過去除鈣和提高鎂,導致對E-鈣粘蛋白-Fc的粘附增加。
The downregulation of Wnt/β-catenin signaling pathway is associated with
zinc deficiency-induced proliferative deficit of C17.2 neural stem cells.
β-catenin信號通路的下調與缺鋅誘導的C17.2神經幹細胞的增殖缺陷相關。